Amlogenyx

Funding and NIH signals

• SEC Form D raise Raised $10M (Form D filed Jul 9, 2026). SEC Form D 0001231919-26-000740 (Jul 9, 2026)
  Evidence (1 event)

  • Jul 9, 2026 · SEC Form D 0001231919-26-000740
    Name of Issuer: Amlogenyx Inc.; CIK: 2031988; Address: Novato, CA; Submission type: D; Filing date: 2026-07-09; Industry Group: Biotechnology; Date of First Sale: 2026-07-01; Types of Securities Offered: Other (Convertible Promissory Notes and equity securities issuable upon conversion thereof); Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 10000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals